J.P. Morgan Private Wealth Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | $354K | Sell |
12,830
-164
| -1% | -$4.52K | ﹤0.01% | 1395 |
|
2023
Q2 | $391K | Sell |
12,994
-1,949
| -13% | -$58.6K | ﹤0.01% | 1127 |
|
2023
Q1 | $541K | Sell |
14,943
-934
| -6% | -$33.8K | ﹤0.01% | 1442 |
|
2022
Q4 | $566K | Sell |
15,877
-1,643
| -9% | -$58.6K | ﹤0.01% | 1419 |
|
2022
Q3 | $593K | Sell |
17,520
-1,309
| -7% | -$44.3K | ﹤0.01% | 1382 |
|
2022
Q2 | $545K | Sell |
18,829
-410
| -2% | -$11.9K | ﹤0.01% | 1426 |
|
2022
Q1 | $622K | Sell |
19,239
-3,356
| -15% | -$109K | ﹤0.01% | 1439 |
|
2021
Q4 | $659K | Buy |
22,595
+1,262
| +6% | +$36.8K | ﹤0.01% | 1440 |
|
2021
Q3 | $569K | Buy |
21,333
+284
| +1% | +$7.58K | ﹤0.01% | 1452 |
|
2021
Q2 | $648K | Buy |
21,049
+42
| +0.2% | +$1.29K | ﹤0.01% | 1386 |
|
2021
Q1 | $550K | Buy |
21,007
+2,248
| +12% | +$58.9K | ﹤0.01% | 1274 |
|
2020
Q4 | $472K | Sell |
18,759
-4,035
| -18% | -$102K | ﹤0.01% | 1313 |
|
2020
Q3 | $475K | Buy |
22,794
+964
| +4% | +$20.1K | ﹤0.01% | 1178 |
|
2020
Q2 | $518K | Buy |
21,830
+3,997
| +22% | +$94.8K | ﹤0.01% | 1074 |
|
2020
Q1 | $321K | Buy |
17,833
+3,560
| +25% | +$64.1K | ﹤0.01% | 1105 |
|
2019
Q4 | $339K | Sell |
14,273
-803
| -5% | -$19.1K | ﹤0.01% | 1185 |
|
2019
Q3 | $414K | Buy |
15,076
+5,178
| +52% | +$142K | ﹤0.01% | 1062 |
|
2019
Q2 | $328K | Sell |
9,898
-281
| -3% | -$9.31K | ﹤0.01% | 1117 |
|
2019
Q1 | $357K | Sell |
10,179
-36
| -0.4% | -$1.26K | ﹤0.01% | 1143 |
|
2018
Q4 | $339K | Sell |
10,215
-489
| -5% | -$16.2K | ﹤0.01% | 1108 |
|
2018
Q3 | $539K | Sell |
10,704
-1,868
| -15% | -$94.1K | ﹤0.01% | 1041 |
|
2018
Q2 | $753K | Buy |
12,572
+1,179
| +10% | +$70.6K | ﹤0.01% | 869 |
|
2018
Q1 | $522K | Buy |
11,393
+649
| +6% | +$29.7K | ﹤0.01% | 851 |
|
2017
Q4 | $428K | Sell |
10,744
-189
| -2% | -$7.53K | ﹤0.01% | 924 |
|
2017
Q3 | $437K | Buy |
10,933
+1,208
| +12% | +$48.3K | ﹤0.01% | 899 |
|
2017
Q2 | $419K | Buy |
9,725
+965
| +11% | +$41.6K | ﹤0.01% | 890 |
|
2017
Q1 | $274K | Buy |
+8,760
| New | +$274K | ﹤0.01% | 1104 |
|
2016
Q1 | – | Sell |
-12,080
| Closed | -$162K | – | 1295 |
|
2015
Q4 | $162K | Buy |
+12,080
| New | +$162K | ﹤0.01% | 1047 |
|